PPARGC1A and dilated cardiomyopathy: Of importance is that ECSW therapy significantly preserved the level of PGC-1α gene expression and mitochondrial cytochrome C and maintained the protein expression of Cx43 in LV myocardium which have been shown to be depressed in the setting of dilated cardiomyopathy [33].